Welcome to
Sanofi U.S.
Worldwide presence
Contact Us
Home
Contact Us
Contact Us
Customer Service
Sanofi US is pleased to answer questions that relate to our company, its products and the therapeutic areas in which we operate. To speed a response to your email question or request, please fill out the fields below with the information required.
Fields marked with
*
are required.
Information about yourself (Please see Sanofi US
Privacy Policy
)
*
Please select the product that your
comment or question relates to:
Adlyxin
ADMELOG® (insulin lispro injection) 100 Units/mL
Alprolix® [Coagulation Factor IX (Recombinant), Fc Fusion Protein]
ALTUVIIIO™ [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl]
Amaryl® (glimepiride tablets)
Ambien CR® (zolpidem tartrate) extended-release tablets
Ambien® (zolpidem tartrate) tablets
Apidra SoloStar
Apidra® (insulin glulisine injection) 100 Units/mL
Arava® (leflunomide) tablets
AUBAGIO® (teriflunomide)
Avalide® (irbesartan-hydrochlorothiazide)
Avapro® (irbesartan)
Cablivi® (caplacizumab-yhdp)
Caprelsa® (vandetanib) Tablets
Clolar® (clofarabine injection)
Dupixent® (dupilumab) Injection
Elitek® (rasburicase)
Eloctate® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]
Eloxatin® (oxaliplatin injection)
ENJAYMO™ (sutimlimab-jome) injection, for intravenous use
Ferrlecit® (sodium ferric gluconate complex in sucrose injection)
Flomax® (tamsulosin HCI)
Hectorol Capsules
Hectorol® (doxercalciferol) Injection
Insulin Glargine injection 100 Units/mL (U-100)
Jevtana® (cabazitaxel) Injection
Kevzara® (sarilumab) Injection
Lantus SoloStar
Lantus® (insulin glargine injection) 100 Units/mL
LEMTRADA® (alemtuzumab)
Leukine
Libtayo
Lovenox® (enoxaparin sodium injection)
Mozobil® (plerixafor) injection
Multaq® (dronedarone)
Nexviazyme™ (avalglucosidase alfa-ngpt)
Praluent
Priftin® (rifapentine) Tablets
Primaquine® (Primaquine Phosphate Tablets)
Renagel® Tablets (sevelamer hydrochloride) 800mg Tablets
Renvela® (sevelamer carbonate)
Rezurock® (belumosudil) tablets
Rifadin® IV (rifampin for injection, USP)
Rifamate
Rifater
Sarclisa® (isatuximab-irfc)
SOLIQUA® 100/33 (insulin glargine and lixisenatide) injection 100 Units/mL and 33 mcg/mL
Synvisc-One® (hylan G-F 20)
Synvisc® (hylan G-F 20)
Taxotere
Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)]
Thyrogen® (thyrotropin alfa)
Toujeo Max SoloStar
Toujeo® (insulin glargine) injection 300 Units/mL
Xenpozyme® (olipudase alfa-rpcp)
Zaltrap® (ziv-aflibercept) Injection for Intravenous Infusion
*
First Name
*
Last Name
*
Address
*
City
*
State
AK
AL
AR
AZ
CA
CO
CT
DC
DE
FL
GA
HI
IA
ID
IL
IN
KS
KY
LA
MA
MD
ME
MH
MI
MN
MO
MS
MT
NC
ND
NE
NH
NJ
NM
NV
NY
OH
OK
OR
PA
RI
SC
SD
TN
TX
UT
VA
VT
WA
WI
WV
WY
AA
AE
AP
AS
FM
GU
MP
PR
PW
VI
*
Zip Code
*
Email address
Please provide a valid email address (i.e., name@domain.com)
*
Phone Number
999-999-9999
Ext
Note: If your question involves MEDICAL or PRODUCT information, we ask that you include a telephone number. This is because certain kinds of questions cannot be answered via email. (Please see Sanofi US
Privacy Policy
)
Fax
Contact Type
Consumer
Direct Purchasing Customer
Non-Health Care Professional
Physician
Employee
Office Staff
Pharmacy-Other
Physicians Assistant
Recruiter
Researcher
Sales Representative
Student
Health Care Professional-Other
Nurse
Pharmacist
Other
Contact Specialty
Allergy/Immunology
Cardiology
Dermatology
Emergency Medicine/Critical Care
Endocrinology
Family Medicine
Gastroenterology
Genetics
Hematology
Hepatology
Infectious Disease
Internal Medicine
Nephrology
Neurology
Obstetrics/Gynecology
Oncology
Opthalmology/Optometry
Orthopedics
Otolaryngology
Pain Medicine
Pediatric
Podiatry
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Transplant
Unspecified
Urology
Vascular Medicine
*
Question (max. 2000 chars.)
Characters Remaining: